
Knight Therapeutics
Specialty pharmaceutical company focused on acquiring or in-licensing.
Market cap
$420m
Enterprise value
$327m
Share price
CAD5.83 GUD.TO
Recent deals
Authorizing premium user...
Specialty pharmaceutical company focused on acquiring or in-licensing.